Works matching IS 1007385X AND DT 2022 AND VI 29 AND IP 8
1
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 8, p. 772, doi. 10.3872/j.issn.1007-385x.2022.08.011
- Article
2
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 8, p. 767, doi. 10.3872/j.issn.1007-385x.2022.08.010
- Article
3
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 8, p. 762, doi. 10.3872/j.issn.1007-385x.2022.08.009
- Article
4
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 8, p. 756, doi. 10.3872/j.issn.1007-385x.2022.08.008
- Article
5
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 8, p. 750, doi. 10.3872/j.issn.1007-385x.2022.08.007
- Article
6
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 8, p. 741, doi. 10.3872/j.issn.1007-385x.2022.08.006
- Article
7
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 8, p. 732, doi. 10.3872/j.issn.1007-385x.2022.08.005
- Article
8
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 8, p. 724, doi. 10.3872/j.issn.1007-385x.2022.08.004
- Article
9
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 8, p. 714, doi. 10.3872/j.issn.1007-385x.2022.08.003
- Article
10
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 8, p. 708, doi. 10.3872/j.issn.1007-385x.2022.08.002
- Article
11
- Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 8, p. 701, doi. 10.3872/j.issn.1007-385x.2022.08.001
- Article